Biotechnology News

July 22, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

July 22, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental Biologics License...

July 22, 2014

GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international laboratory and pharmaceutical equipment supplier, successfully closed the first half of 2014 with significant gains. Consolidated order intake grew 8.9% in...

July 21, 2014

SAN DIEGO--(BUSINESS WIRE)--Assay Depot Inc., the pharmaceutical industry’s leading marketplace for scientific services, today announced a partnership to build an academic Research Exchange for use by scientists at ten leading research hospitals...

July 21, 2014

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. (Nasdaq: CLVS) will announce its second quarter 2014 financial results on Thursday, August 7, 2014, after the close of the U.S. financial markets. Clovis’ senior management will host a...

July 21, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Announces Advancement of Ganetespib into Phase 3 Extension of AML LI-1 Study for Patients with AML and High-Risk MDS

July 21, 2014

DUBLIN & LEXINGTON, Mass.--(BUSINESS WIRE)--Jazz Pharmaceuticals and Concert Pharmaceuticals initiated a first-in-human Phase 1 study with JZP-386.

July 21, 2014

ST. PAUL, Minn.--(BUSINESS WIRE)--World leaders and celebrities came to St. Paul, Minn. to support and celebrate the Starkey Hearing Foundation’s 14th annual So the World May Hear Awards Gala. The event raised more than $8.7 million.

July 21, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO) (Euronext Paris - BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced the launch of Sitavig® (acyclovir...

July 21, 2014

ANTONY, France--(BUSINESS WIRE)--STALLERGENES (Paris:GENP), a global healthcare company specialized in the diagnosis and treatment of allergies through allergen immunotherapy-based solutions, announced today the acquisition of the entire share...

July 21, 2014

BAGNEUX, France--(BUSINESS WIRE)--Reaching significant milestones within the framework of the partnership with Quest Diagnostics.

July 21, 2014

ROSWELL, Ga.--(BUSINESS WIRE)--CorMatrix Cardiovascular announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market the CorMatrix® ECM® for Vascular Repair. The CorMatrix ECM for Vascular Repair is intended...

July 21, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Biolase to Raise $12 Million from Institutional and Individual Investors in Private Placement

July 21, 2014

BALTIMORE--(BUSINESS WIRE)--Cerecor closes on first tranche of $32M Series B financing for its lead candidate, CERC-301, as an adjunctive antidepressant with rapid onset of action, and COMT inhibitor platform.

July 21, 2014

BOSTON--(BUSINESS WIRE)--Flex Pharma, Inc. is a biopharmaceutical company dedicated to creating innovative, novel treatments for neuromuscular disorders. Flex Pharma has demonstrated initial human efficacy related to muscle cramping in healthy...

July 21, 2014

DENVER--(BUSINESS WIRE)--Colorado BioScience Association (CBSA) is honored to announce the Amgen Foundation’s grant of $25,000 to the Colorado BioScience Institute (CBSI) in support of the RET program.

July 21, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--ABL, Inc. announces the acquisition of a majority interest in Platine Pharma Services. The acquisition will expand ABL's capabilities in immunological assay services and provide a presence in Europe.

July 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics announced that the underwriters of its initial public offering (IPO) exercised in full their option to purchase from SAGE 750,000 additional shares of its common stock.

July 21, 2014

BERKELEY, Calif.--(BUSINESS WIRE)--Aduro BioTech, Inc., a clinical-stage biotechnology company, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for its pancreatic cancer combination...

July 21, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) today announced operating results for the quarter ended June 30, 2014. Allergan also announced that its Board of Directors has declared a second quarter dividend of $0.05 per share,...

July 21, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Proteon Therapeutics initiates Phase 3 clinical study of its lead product, PRT-201, in patients with chronic kidney disease undergoing surgical placement of an arteriovenous fistula for hemodialysis

July 21, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Genocea commences a phase 2 dose optimization trial for GEN-003, the company's immunotherapy against herpes simplex-type 2.

July 21, 2014

READING, England--(BUSINESS WIRE)--Quintiles has been named Britain's Healthiest Large Workplace

July 21, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced the successful completion of the acquisition of Labrys. The acquisition of Labrys brings to Teva LBR-101, a fully humanized monoclonal antibody that binds...

July 21, 2014

SAN DIEGO--(BUSINESS WIRE)--Ignyta, Inc. (Nasdaq: RXDX), an oncology precision medicine biotechnology company, today announced the multicenter initiation of the company’s global Phase I/II clinical trial of RXDX-101, its proprietary oral tyrosine...

July 21, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--MicroCHIPS, Inc., a developer of implantable drug delivery devices, today announced that its Board of Directors has appointed Cheryl R. Blanchard, Ph.D., as Chief Executive Officer.

July 21, 2014

PALO ALTO, Calif.--(BUSINESS WIRE)--Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC) today announced that it has entered into an exclusive agreement with Sandoz Inc., a Novartis company, pursuant to which Sandoz will distribute and commercialize Anacor...

July 21, 2014

BEIJING & SAN DIEGO--(BUSINESS WIRE)--Berry Genomics Co. Ltd. announced today it has chosen Illumina Inc’s. (NASDAQ: ILMN) next-generation sequencing (NGS) technology as the platform on which Berry will secure Chinese Food and Drug...

July 21, 2014

SUNNYVALE, Calif.--(BUSINESS WIRE)--Optra Health’s powerful ‘Automation of Knowledge’ solution transforms unstructured biological data into an insightful medical knowledge database enabling effective use of Next Generation Sequencing.

July 21, 2014

MEQUON, Wis.--(BUSINESS WIRE)--Titan Spine, a medical device surface technology company focused on developing innovative spinal interbody fusion implants, today announced that a research paper which evaluated their surface technology was awarded...

July 21, 2014

ESSEN, Germany--(BUSINESS WIRE)--Surgeons of the University Hospital Essen Complete World’s First Robotic-Assisted Cancer Surgery with Medrobotics‘ Flex® System

July 18, 2014

BEDFORD, Mass.--(BUSINESS WIRE)--Clinical results of patients treated with ConforMIS iTotal® customized knee implants presented at the 2014 International Congress for Joint Reconstruction (ICJR)

July 18, 2014

AUSTIN, Texas--(BUSINESS WIRE)--Brainlab, a global leader in medical technology, announced today the release of ELEMENTS Automatic Brain Metastases Planning.

July 18, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced the setup of a €10 million loan granted by its top shareholder...

July 18, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announced today that it will release its second quarter 2014 financial results on Thursday, July 31, 2014 at 7:00 a.m. ET. Teva will host a conference call and live...

July 18, 2014

CINCINNATI--(BUSINESS WIRE)--Symplmed announced today that it has acquired U.S. rights to ACEON® (perindopril erbumine tablets), an angiotensin converting enzyme (ACE) inhibitor approved to treat patients with high blood pressure (hypertension)...

July 18, 2014

BURLINGTON, N.C.--(BUSINESS WIRE)--Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended June 30, 2014. Second Quarter Results Sales for the quarter were approximately $1.52 billion, an...

July 18, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that the Company will host a conference call...

July 18, 2014

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today that its President and CEO, Samuel Wagner, was interviewed by CEOCFO Magazine, a weekly industry publication that conducts in depth interviews with corporate executives. The interview...

July 17, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics, Inc., a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, announced the pricing of its IPO.

July 17, 2014

WASHINGTON--(BUSINESS WIRE)--Because of the environmental, economical and societal benefits they provide, genetically engineered (GE) varieties of soybeans, cotton and corn are the preferred choice of U.S. farmers according USDA.

July 17, 2014

PORTLAND, Ore.--(BUSINESS WIRE)--DesignMedix, Inc., a biotech company that develops drugs to overcome drug resistance, has closed a second, $1.5 million round of angel funding from investors in the Northwest.

July 17, 2014

WASHINGTON--(BUSINESS WIRE)--Programming at BIO's Livestock Biotech Summit will address new methods for ensuring optimal care and use of agricultural animals for a range of applications. The 2014 Summit will be held in September.

July 17, 2014

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, August 11, 2014. Management will hold a conference call to...

July 17, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea Biopharmaceuticals announced the results of voting at its 2014 Annual Meeting of Stockholders (the Annual Meeting) held July 17, 2014.

July 17, 2014

TORRANCE, Calif.--(BUSINESS WIRE)--Phenomenex Inc. will spin off a company named Neoteryx LLC to deliver novel microsampling products that provide less invasive, simpler solutions for collecting and testing biological samples.